Fellow of The Academy of Medical Sciences, United Kingdom
His primary areas of investigation include Asthma, Internal medicine, Immunology, Sputum and Eosinophil. The study incorporates disciplines such as Eosinophilia, Respiratory disease and Randomized controlled trial in addition to Asthma. His Internal medicine research integrates issues from Gastroenterology and Placebo.
The various areas that Ian D. Pavord examines in his Immunology study include Bronchoalveolar lavage and Eosinophilic. His Sputum study integrates concerns from other disciplines, such as Prostaglandin and Surgery. The concepts of his Eosinophil study are interwoven with issues in Inhalation and Anti-asthmatic Agent.
Asthma, Internal medicine, Immunology, Sputum and COPD are his primary areas of study. His studies deal with areas such as Randomized controlled trial, Airway and Intensive care medicine as well as Asthma. The Internal medicine study combines topics in areas such as Gastroenterology and Placebo.
The study of Immunology is intertwined with the study of Eosinophilic in a number of ways. His Sputum study combines topics in areas such as Respiratory disease and Spirometry. Ian D. Pavord has included themes like Biomarker and Pulmonary disease in his COPD study.
His main research concerns Internal medicine, Asthma, Dupilumab, In patient and Intensive care medicine. The study incorporates disciplines such as Gastroenterology and Placebo in addition to Internal medicine. Ian D. Pavord interconnects Post-hoc analysis and Eosinophil in the investigation of issues within Placebo.
His biological study focuses on Exhaled nitric oxide. His Intensive care medicine research includes elements of Inhaled corticosteroids, Precision medicine and MEDLINE. In his work, Eosinophilic and Immunology is strongly intertwined with Sputum, which is a subfield of Mepolizumab.
Ian D. Pavord mostly deals with Asthma, Internal medicine, Intensive care medicine, MEDLINE and Exhaled nitric oxide. His study in Asthma focuses on Asthma Control Questionnaire in particular. His study connects Placebo and Internal medicine.
His biological study spans a wide range of topics, including Precision medicine, Inhalation, Guideline, Inhaled corticosteroids and Asthma control. His Exhaled nitric oxide study combines topics from a wide range of disciplines, such as Gastroenterology and Inhaler. Within one scientific family, Ian D. Pavord focuses on topics pertaining to Immunology under COPD, and may sometimes address concerns connected to Fibrocyte and Prostaglandin D2.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
Ruth H Green;Christopher E Brightling;Susan McKenna;Beverley Hargadon.
The Lancet (2002)
Cluster analysis and clinical asthma phenotypes.
Pranab Haldar;Ian D. Pavord;Dominic E. Shaw;Michael A. Berry.
American Journal of Respiratory and Critical Care Medicine (2008)
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Pranabashis Haldar;Christopher E. Brightling;Beverley Hargadon;Sumit Gupta.
The New England Journal of Medicine (2009)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
Ian D Pavord;Stephanie Korn;Peter Howarth;Eugene R Bleecker.
The Lancet (2012)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega;Mark C. Liu;Ian D. Pavord;Guy G. Brusselle.
The New England Journal of Medicine (2014)
Mast-Cell Infiltration of Airway Smooth Muscle in Asthma
Christopher E. Brightling;Peter Bradding;Fiona A. Symon;Stephen T. Holgate.
The New England Journal of Medicine (2002)
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.
Helen K. Reddel;D. Robin Taylor;Eric D. Bateman;Louis-Philippe Boulet.
American Journal of Respiratory and Critical Care Medicine (2009)
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Elisabeth H. Bel;Sally E. Wenzel;Philip J. Thompson;Charlene M. Prazma.
The New England Journal of Medicine (2014)
British guideline on the management of asthma: A national clinical guideline
Graham Douglas;Bernard Higgins;Neil Barnes;Anne Boyter.
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids
R H Green;C E Brightling;G Woltmann;D Parker.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: